SOURCE: Healtheuniverse Inc.

February 15, 2007 09:12 ET

Healtheuniverse Adult Stem Cell Line to Offer Alternative to Embryonic Stem Cells for Medical Therapies

COVINA, CA -- (MARKET WIRE) -- February 15, 2007 -- Healtheuniverse Inc. (PINKSHEETS: HLUN), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announced today intellectual property in development is moving toward a progenitor cell line offering an alternative to human embryonic stem cells for medical therapies. Adipose tissue, also known as fat, is an abundant source of stem cells and other regenerative cells which provide the promise of stem cell medical breakthroughs while avoiding the controversy surrounding destruction of embryos.

Major commercial applications for the progenitor cell line in development will be utilized for both non-surgical and surgical areas. Non-surgical applications will initially focus on skin rejuvenation and minor wound reparative processes. Surgical applications in process are addressing major wound repair and reconstructive areas such as formation of new skin and bone.

"Adipose tissue has the potential to be engineered for plastic surgery and reconstructive surgery cases performed daily in our clinics in California," stated Dr. Vipul Dev, MD, Chief Executive Officer of Healtheuniverse Inc. "The engineered tissue can initially be used to repair facial deformities, breast reconstruction, and various wounds or defects caused by disease or trauma."


HEALTHeUNIVERSE Inc. is engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in disease related commercial applications. More information on Healtheuniverse is available online at

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse Inc.
    Investor Relations
    Email Contact